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A B S T R A C T   
Pancreatic cystosis (PC) is an uncommon manifestation of pancreas involvement in cystic fibrosis (CF), char-
acterized by the presence of multiple macrocysts partially or completely replacing pancreas. Only few reports are 
available from literature and management (surgery vs follow up) is commonly based on the presence of symp-
toms or complications due to local mass effect, although evidence-based recommendations are still not available. 
We here report the case of a young adult CF patient with PC, in which cardiopulmonary exercise testing 
(CPET) provided important information to be integrated to the radiological finding of inferior vena cava 
compression by the multicystic pancreas complex. Through the analysis of oxygen kinetic cardiodynamic phase 
pattern, CPET may be helpful to safely exclude significant mass effects on blood venous return and to improve 
the decision-making process on whether to consider surgery or not in patients with PC.   
1. Introduction 
Cystic fibrosis (CF) is the most common lethal autosomal recessive 
genetic disorder among Caucasians, with highest prevalence in Europe, 
North America and Australia, occurring in approximately 1 in 2500 live- 
births [1]. Mutations in the cystic fibrosis transmembrane conductance 
regulator (CFTR) are responsible for the pathogenesis of the disease. 
CF is a multi-system disease classically involving upper and lower 
airways, pancreas, liver and the reproductive tract. Typically, pancreatic 
involvement results in partial or complete replacement by fibro-fatty 
tissue, diffuse pancreatic fibrosis, pancreas atrophy and multiple cysts. 
Whilst small pancreatic cysts are relatively common, the finding of 
multiple macrocysts (i.e. > 1 cm in size) replacing pancreas is a rare 
complication of CF and is referred to as pancreatic cystosis (PC) [2]. 
Pathophysiology of PC is postulated to be related to the intra-ductal 
defective bicarbonate secretion secondary to the CFTR channel 
dysfunction, leading to inspissated secretions, increased pressure within 
pancreatic ducts and transformation into various-sized cysts [3]. 
Most patients are asymptomatic, with radiographic findings discov-
ered incidentally on ultrasound or magnetic resonance imaging (MRI), 
usually during the second decade of life [4]. When present, symptoms 
occur secondary to mass-effect, vascular compromise and/or intra-cystic 
hemorrhage. Management is based purely on symptoms and/or com-
plications, with no influence exerted by cyst size. If symptoms warrant 
intervention, either pancreatectomy or endoscopic cystogastrostomy are 
the only available surgical options [2]. 
We here report a case of PC in which cardiopulmonary exercise 
testing (CPET) helped define the functional consequences of compres-
sion of the inferior vena cava (IVC) found at imaging. 
1.1. Oxygen kinetics to assess venous return: rationale 
In a given individual, the profile of oxygen consumption (V’O2) by 
peripheral muscles and lungs following the onset of constant-work rate 
exercise may be defined with respect to the exercise intensity domain in 
which the exercise itself is performed which, in turn, is determined by 
clusters of common metabolic responses evoked. 
Specifically, as shown in Fig. 1, for moderate intensity exercise (i.e. 
before the onset of a substantial anaerobic metabolism, so called lactate 
threshold, θL), V’O2 measured at the lungs follows a three-phase kinetic 
[5]. Phase I (also called cardiodynamic component) is usually charac-
terized by an immediate increase in oxygen uptake at the start of exer-
cise, lasting for 15–20 seconds. It is accounted for by the abrupt rise in 
pulmonary blood flow secondary to an almost immediate increase in 
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heart rate, stroke volume and, therefore, cardiac output, facilitated 
principally by the instantaneous vagal withdrawal and the mechanical 
pumping action of the contracting muscles. Phase II (primary compo-
nent) is defined by the exponential growth in V’O2 values reflecting the 
period of major increase in cellular respiration and lasting approxi-
mately 3–4 minutes, until the achievement of a steady state for V’O2 
(phase III) [5,6]. 
Phase I is believed to be driven by the increase in pulmonary blood 
flow in the absence of altered arterial or venous O2 contents [6,7]. 
Indeed, lung V’O2 is the product of cardiac output times the 
arterial-venous O2 content difference. The exponential increase in 
muscle O2 uptake at exercise onset and the sequelae for muscle-venous 
and mixed-venous blood composition are not immediately expressed at 
the lungs, being delayed by the so-called muscle-to-lung transit delay. As 
the arterial-venous O2 content difference is effectively unchanged from 
rest over this interval, the increase in pulmonary V’O2 is determined by 
cardiac output only or, strictly speaking, pulmonary blood flow which is 
a direct consequence of an equal increase in venous return to the right 
atrium [7]. 
2. Case presentation 
A 24-year-old male affected by CF came to our attention looking for a 
second opinion about surgical indication due to PC determining 
compression on IVC. CF diagnosis was made through newborn screening 
and subsequent CFTR genotyping revealed homozygosis for F508del 
mutation. CF-related complications included chronic airways infection 
by Pseudomonas aeruginosa, Staphylococcus aureus and Stenotrophomonas 
maltophilia, exocrine pancreatic insufficiency, chronic rhinosinusitis, 
cholelithiasis and nephrolithiasis. Other non-CF comorbidities included 
β thalassemia minor and hypersensitivity to Dermatophagoides pter-
onyssinus. At the time of evaluation, he still had a preserved lung func-
tion (forced expiratory volume in the 1st second, FEV1: 3.73 L, 87% 
predicted value; forced vital capacity, FVC: 4.64 L, 92% predicted value) 
as well as a good nutritional status (body mass index: 21.7 kg/m2). 
PC was first found incidentally seven years before, during routine 
abdominal ultrasound. Since then, patient performed regular follow up 
with ultrasound (annually) and RMI (biannually), showing very slow but 
progressive growth of multiple cysts mainly involving the head and the 
Fig. 1. Abdominal MRI showing multicystic trans-
formation of the entire pancreas consistent with the 
diagnosis of pancreatic cystosis. A) T2-weighted Half 
fourier Single-shot Turbo spin-Echo (HASTE) 
sequence coronal section showing the multicystic 
complex long- (l) and short-axis (s) diameters, 
measuring 87.4 mm and 68.6 mm, respectively; B) 
T2-weighted coronal volumetric reconstruction of 
biliary tree showing the well-defined hyperintense 
multicystic complex; C) Fat saturated T2-weighted 
sequence axial section showing the compression of 
the subrenal trait of the inferior vena cava anterior 
wall (white arrow) by the cystic complex (see main 
text for further details).   
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uncinate process of the pancreas. Patient denied symptoms such as 
abdominal pain, nausea, fullness as well as episodes of mechanical in-
testinal occlusion. A palpable, painless mass in mesogastrium, with no 
defined limits, was appreciable at physical examination. No evidence of 
jaundice, peripheral edema and collateral venous circulation was found. 
Abdominal MRI was repeated (Fig. 2), which showed multicystic 
transformation of the entire pancreas with no residual normal paren-
chymal tissue and no pancreatic duct dilation. The whole multicystic 
complex measured 69x60  87 mm, apparently unchanged over the last 
two years, determining a mild widening of the duodenal C-loop. The 
largest cyst’s diameter measured 2 cm. Bile ducts were poorly appre-
ciable due to massive local anatomical changes. Infusion of gadolinium 
contrast medium confirmed the compression of the subrenal trait of the 
IVC against lumbar backbone. Finding of two subcentrimetric gallstones 
was confirmed as well. Liver, spleen, kidneys and adrenal glands were 
apparently unaffected. 
2.1. Patient’s oxygen kinetics 
Incremental symptom-limited CPET was first performed on an elec-
tronically braked cycle ergometer through automated testing system 
(OMNIA, Cosmed, Rome, Italy) to identify θL. The test was performed 
with a 10 W/min incremental work rate protocol until physical 
exhaustion. θL occurred at work rate of 70 W, corresponding to a V’O2 
value of 16.9 ml/min/kg (36.7% of maximal V’O2 predicted). A tailored 
constant work rate CPET was then performed 24 hours later at a mod-
erate exercise intensity (i.e. below θL) of 50 W. No warm-up was per-
formed to avoid misinterpretation of oxygen kinetics phase I. 
As shown in Fig. 3, the three phases of oxygen kinetics were clearly 
discernible: after 20 sec of rapid increase in V’O2 values (phase I), 
exponential rise in V’O2 (phase II) was observed and steady state (phase 
III) was finally reached after  4 min from the beginning of exercise. 
V’O2 averaged value at rest was 491.4 ml/min, while at steady state was 
1375 ml/min. Hence, rest-to-steady state rise in V’O2 (ΔV’O2) was 883.6 
ml/min, with approximately 441.6 ml/min increase recorded during 
phase I only (89.9% from baseline, 49.9% of ΔV’O2). 
3. Discussion 
PC is a rare complication of CF with an unknown prevalence due to 
the paucity of information available from literature, mostly represented 
by case series [8–18]. A recent systematic review on this topic was 
published by Desai CS et al. [4], who identified 19 papers describing a 
total of 24 cases only of PC since 1981. Despite the lack of proper 
evidence-based recommendations, there is common agreement that the 
clinical management of PC should be driven by symptoms and/or 
abdominal complications secondary to cysts mass-effect or hemorrhage 
[2]. 
As for our patient, the great majority of reported cases are charac-
terized by asymptomatic individuals with incidental finding of PC who 
were suggested to continue with radiological follow up. Surgery has 
been described in few cases only for symptomatic patients, with in-
terventions going from endoscopic cystogastrostomy to laparotomy with 
partial to total pancreatectomy [4,16,17], the latter recently described 
in association with islet cell autotransplantation [8]. In all these cases, 
no mention was done of compression on major abdominal vessels and 
hemodynamic consequences arising from PC. To our knowledge, this is 
the first case described of PC where decision making, i.e. whether un-
dergoing surgery or not, was specifically focused on the presence of 
functional effects stemming from IVC mechanical compression. 
In this situation, CPET may represent a helpful diagnostic tool, 
allowing non-invasive assessment of venous return through the analysis 
of oxygen kinetics during constant-work rate exercise at a moderate 
intensity (i.e. below θL). The point has been made clear previously that, 
in this condition, the rapid increase in V’O2 values during phase I rep-
resents an indirect index of the lack of abnormalities in right heart 
cardiac output which, in subjects with no evidence of increased pul-
monary blood pressure, is directly related to venous return. 
Though, it must be clarified that no reference values are available to 
define a normal/abnormal response, specifically with regard to the 
magnitude of V’O2 response during phase I [19]. Nonetheless, previous 
studies observed that among healthy individuals, at the end of phase I, 
V’O2 approximately doubles its resting value [6,20], corresponding to 
approximately 50  11% of rest-to-steady state change in V’O2 [21]. 
These values are significantly reduced among patients affected by car-
diovascular diseases with increased right heart pressures, such as 
chronic heart failure and cyanotic congenital heart diseases. In our case, 
we observed a change in V’O2 which almost doubled its resting value 
(89.9% from baseline) and corresponded to half the change in V’O2 
during the exercise testing, which is comparable to the response typi-
cally observed in healthy individuals. Answering the patient’s clinical 
question, we non-invasively excluded functional abnormalities arising 
from IVC compression by multiple pancreatic cysts and confirmed the 
absence of any clear indication to surgery; he was therefore suggested to 
continue with regular follow up through ultrasound and MRI. 
4. Conclusion 
PC is a rare complication of CF, with still little information available 
on proper management. Surgery is indicated for patients with abdom-
inal symptoms and complications manifestly related to mass-effect. 
Although, functional complications secondary to compression ab 
extrinseco on main abdominal vessels may be difficult to assess. Referral 
to a highly specialized center in exercise physiology and evaluation of 
the cardiodynamic component of oxygen kinetics during CPET may add 
valuable information for the management of these cases. 
Consent for publication 
Written informed consent was obtained from the patient for anony-
mous publication of this case report. A copy of written consent is 
available upon request. 
Fig. 2. Schematic representation of physiologic responses to constant-work rate 
exercise below lactate threshold. The three phases (I, II, III) of oxygen uptake 
(V’O2) kinetics are shown. Note that for the great majority of phases I and II 
muscle V’O2 is not immediately expressed at the lungs, being delayed by the 
muscle-to-lung transit delay. Indeed, during phase I, changes in V’O2 measured 
at the lungs are secondary to the increase in cardiac output (Q0), whilst modi-
fications in arterial-venous oxygen content (C (a-v)O2) begins and are 
accounted for only after some time from the beginning of physical effort (i.e. 
end of phase I). See main text for further explanations. 
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